CK 2289

inotropic agent with potential utility in treatment of congestive heart failure; structure given in first source; RN from Toxlit

Also Known As:

CK-2289

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Heart Failure 01/01/1991 - "CK-2289 is an inhibitor of type III cyclic 3'5'-adenosine monophosphate phosphodiesterase with potential utility in the treatment of congestive heart failure. "

1.	Phosphoric Diester Hydrolases (Phosphodiesterases)